Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
IQV
IQVIA Inc€1,450
2USOA
Feb 17, 2021
currency
EUR
size (m)
550.000
maturity
Mar 15, 2026
type
Fixed
tenor
5.000
call
2
registration
144A/Reg S
benchmark
-
ranking
-
moody's
Ba3
s&p
BB
fitch
-
size description
-
re-open/tap
No
ipt
2.00%-2.25%
ipt-pxd
-
guidance
1.75%-1.875%
spread
240
coupon
1.750%
spread set
-
price
100.00000
yield
1.750%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, GSC, HSB, ...
joint leads
-
passive leads
-
co-managers
BBV, BNP, CTI, FTB, ...
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, GSC, HSB, ...
joint leads
-
passive leads
-
co-managers
BBV, BNP, CTI, FTB, ...
coordinating managers
-
currency
EUR
size (m)
900.000
maturity
Mar 15, 2029
type
Fixed
tenor
8.000
call
3
registration
144A/Reg S
benchmark
-
ranking
-
moody's
Ba3
s&p
BB
fitch
-
size description
-
re-open/tap
No
ipt
2.50% area
ipt-pxd
-
guidance
2.25%-2.50%
spread
273
coupon
2.250%
spread set
-
price
100.00000
yield
2.250%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, GSC, HSB, ...
joint leads
-
passive leads
-
co-managers
BBV, BNP, CTI, FTB, ...
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, GSC, HSB, ...
joint leads
-
passive leads
-
co-managers
BBV, BNP, CTI, FTB, ...
coordinating managers
-
Tranche Comments
Redemption: 2023-03-15; Registration: 144A/Reg S; Comments: 02/17/2021 IQVIA Inc (IQV) EUR1.45bn 144A/Reg S sr notes 2-part. Ba3/BB (stable/stable). Via JPM (sole physical books, B&D)/Barc/BofA/GS/HSBC/WFS joint books, Citi, FITB, PNC, Mizuho, MUFG, TD, TSI, BBVA, BNPP, Huntington, RBC, Siebert Willliams as co-managers. No reg rights. List ISE. NY law. Settles 03/03 (T+10). - EUR550m (from minimum EUR400m) due 03/15/26 (5y). NC2 (03/15/23) (MWC B+50bp), then at 100.875, 100.438, 100. Equity claw: 2y 40% at 101.75. Reg S ISIN: XS2305742434. IPT: 2.00%-2.25%. Px talk: 1.75%-1.875%. Final pricing: EUR550m at 1.75%. Priced: 1.75% at 100. +240bp vs DBR 0.5% 02/15/26. - EUR900m due 03/15/29 (8y). NC3 (MWC B+50bp), then at 101.125, 100.563, 100. Equity claw: 3y 40% at 102.25. Reg S ISIN: XS2305744059. IPT: 2.50% area. Px talk: 2.25%-2.50%. Final pricing: EUR900m at 2.25%. Priced: 2.25% at 100. +273bp vs DBR 0.25% 02/5/29. Did global investor call at 1pm UKT 02/16 (virtual 1x1 meetings were also available 02/16). Books closed at 2pm UKT 0217. UOP: redeem its EUR1.425bn 3.25% sr notes due 03/15/25 (callable at 100.813 on 03/15/21). Biz: leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. HQ: Durham, NC and Danbury, CT.; Redemption: 2024-03-15; Registration: 144A/Reg S; Comments: 02/17/2021 IQVIA Inc (IQV) EUR1.45bn 144A/Reg S sr notes 2-part. Ba3/BB (stable/stable). Via JPM (sole physical books, B&D)/Barc/BofA/GS/HSBC/WFS joint books, Citi, FITB, PNC, Mizuho, MUFG, TD, TSI, BBVA, BNPP, Huntington, RBC, Siebert Willliams as co-managers. No reg rights. List ISE. NY law. Settles 03/03 (T+10). - EUR550m (from minimum EUR400m) due 03/15/26 (5y). NC2 (03/15/23) (MWC B+50bp), then at 100.875, 100.438, 100. Equity claw: 2y 40% at 101.75. Reg S ISIN: XS2305742434. IPT: 2.00%-2.25%. Px talk: 1.75%-1.875%. Final pricing: EUR550m at 1.75%. Priced: 1.75% at 100. +240bp vs DBR 0.5% 02/15/26. - EUR900m due 03/15/29 (8y). NC3 (MWC B+50bp), then at 101.125, 100.563, 100. Equity claw: 3y 40% at 102.25. Reg S ISIN: XS2305744059. IPT: 2.50% area. Px talk: 2.25%-2.50%. Final pricing: EUR900m at 2.25%. Priced: 2.25% at 100. +273bp vs DBR 0.25% 02/5/29. Did global investor call at 1pm UKT 02/16 (virtual 1x1 meetings were also available 02/16). Books closed at 2pm UKT 0217. UOP: redeem its EUR1.425bn 3.25% sr notes due 03/15/25 (callable at 100.813 on 03/15/21). Biz: leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. HQ: Durham, NC and Danbury, CT.;

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.